Preferred Label : Paxlovid;
Origin ID : M000753048;
Related record
https://sante.gouv.fr/IMG/pdf/annexe_1_-_dgs_urgent_2023-05.pdf
2023
France
public health guidelines
Paxlovid
effects of exposure to external cause, nos
target population
judgment
health services needs and demand
population groups
Pre-Exposure Prophylaxis
prophylactic treatment, nos
Evusheld
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-du-nirmatrelvir-ritonavir-paxlovidmc.html
2023
Canada
guidelines for drug use
Nirmatrelvir/Ritonavir
Paxlovid
Usage
Optimum
---
https://www.has-sante.fr/jcms/p_3334227/fr/paxlovid-pf-07321332-/-ritonavir-covid-19
2022
false
false
false
France
COVID-19
evaluation of the transparency committee
ritonavir
PF-07321332
Paxlovid
---
https://www.cmg.fr/wp-content/uploads/2022/05/Infog-Paxlovid-23-mai-2022.pdf
2022
false
false
false
France
COVID-19
scientific and technical information
Paxlovid
---
https://www.cnge.fr/conseil_scientifique/productions_du_conseil_scientifique/avis_du_conseil_scientifique/paxlovid/
2022
false
false
false
France
COVID-19
scientific and technical information
Paxlovid
---
https://sante.gouv.fr//IMG/pdf/dgs-urgent_no2022_80_-_annexe_prescrire_le_traitement_antiviral_paxlovid.pdf
2022
France
scientific and technical information
Antiviral agents
Paxlovid
Antiviral drugs
antiviral agents
---
https://sfpt-fr.org/recospaxlovid
2022
France
guideline
drug, nos
Treatments
health planning guidelines
combined modality therapy
Paxlovid
Treatments
drug combinations
drug therapy, combination
---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/Recommandations%20SFPT%20Interactions%20Paxlovid.pdf
2022
France
practice guideline
Paxlovid
drug therapy, combination
combined modality therapy
health planning guidelines
drug combinations
drug, nos
Treatments
Treatments
---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/Guide%20de%20bon%20usage%20PAXLOVID.pdf
2022
France
guidelines for drug use
Handbook
Paxlovid
---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-utilisation-antiviral-paxlovid
2022
France
technical report
Paxlovid
antiviral agents
mouth, nos
Antiviral agents
data collection
Antiviral drugs
---
https://sante.gouv.fr//IMG/pdf/dgs-urgent__2022_22_paxlovid.pdf
2022
false
false
false
France
COVID-19
nirmatrelvir and ritonavir drug combination
nirmatrelvir
nirmatrelvir and ritonavir
scientific and technical information
laboratories
Paxlovid
devices
tablets
dandruff
association
ritonavir
PF-07321332
antiviral agents
Set, Psychology
seborrhea sicca
Antiviral agents
Antiviral drugs
device, nos
---
https://www.has-sante.fr/jcms/p_3310993/fr/traitement-par-antiviral-des-patients-a-risque-de-forme-grave-de-la-covid-19
2022
false
false
false
France
COVID-19
severe COVID-19
adult
Paxlovid
nirmatrelvir and ritonavir drug combination
primary health care
drug interactions
nirmatrelvir
ritonavir
guideline
antiviral agents
risk
COVID-19
---
https://sante.gouv.fr//IMG/pdf/dgs-urgent_no2022_80_-_dispositif_d_appui_a_la_prescription_de_paxlovid.pdf
2022
France
scientific and technical information
Set, Psychology
equipment and supplies
Paxlovid
device, nos
prescription, nos
devices
---
